{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:13:54Z","timestamp":1792656834060,"version":"4.5.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002160","name":"Jain Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002160","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Canadian Foundation for Innovation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Skeletal Muscle"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13395-017-0135-9","type":"journal-article","created":{"date-parts":[[2017,9,12]],"date-time":"2017-09-12T14:01:34Z","timestamp":1505224894000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy"],"prefix":"10.1186","volume":"7","author":[{"given":"Nadia","family":"Milad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash Y.","family":"Tehrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Sellers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio M.V.","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Bernatchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,12]]},"reference":[{"issue":"4","key":"135_CR1","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1083\/jcb.122.4.809","volume":"122","author":"JM Ervasti","year":"1993","unstructured":"Ervasti JM, Campbell KP. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol. 1993;122(4):809\u201323.","journal-title":"J Cell Biol"},{"key":"135_CR2","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1073\/pnas.90.8.3710","volume":"90","author":"BJ Petrof","year":"1993","unstructured":"Petrof BJ, et al. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci U S A. 1993;90:3710\u20134.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"135_CR3","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1083\/jcb.150.5.1209","volume":"150","author":"IN Rybakova","year":"2000","unstructured":"Rybakova IN, Patel JR, Ervasti JM. The dystrophin complex forms a mechanically strong link between the sarcolemma and costameric actin. J Cell Biol. 2000;150(5):1209\u201314.","journal-title":"J Cell Biol"},{"issue":"2","key":"135_CR4","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1083\/jcb.139.2.375","volume":"139","author":"V Straub","year":"1997","unstructured":"Straub V, et al. Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J Cell Biol. 1997;139(2):375\u201385.","journal-title":"J Cell Biol"},{"key":"135_CR5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","volume":"9","author":"K Bushby","year":"2010","unstructured":"Bushby K, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis and pharmacological and psychosocial management. Lancet Neurol. 2010;9:77\u201393.","journal-title":"Lancet Neurol"},{"issue":"1","key":"135_CR6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0960-8966(91)90039-U","volume":"1","author":"AEH Emery","year":"1991","unstructured":"Emery AEH. Population frequencies of inherited neuromuscular diseases\u2014a world survey. Neuromuscul Disord. 1991;1(1):19\u201329.","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"135_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pediatrneurol.2006.09.016","volume":"36","author":"N Deconinck","year":"2007","unstructured":"Deconinck N, Dan B. Pathophysiology of duchenne muscular dystrophy: current hypotheses. Pediatr Neurol. 2007;36(1):1\u20137.","journal-title":"Pediatr Neurol"},{"issue":"1","key":"135_CR8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.pmr.2011.11.014","volume":"23","author":"JN Kornegay","year":"2012","unstructured":"Kornegay JN, et al. The paradox of muscle hypertrophy in muscular dystrophy. Phys Med Rehabil Clin N Am. 2012;23(1):149\u201372. xii","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"135_CR9","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/mus.10435","volume":"28","author":"KL Tyler","year":"2003","unstructured":"Tyler KL. Origins and early descriptions of \u201cDuchenne Muscular Dystrophy\u201d. Muscle Nerve. 2003;28:402\u201322.","journal-title":"Muscle Nerve"},{"key":"135_CR10","doi-asserted-by":"crossref","unstructured":"Emery, A.E.H., F. Muntoni, and R.C.M. Quinlivan, Duchenne Muscular Dystrophy. Fourth Edition ed; 2015.","DOI":"10.1093\/med\/9780199681488.001.0001"},{"issue":"1","key":"135_CR11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1586\/14779072.5.1.99","volume":"5","author":"D Townsend","year":"2007","unstructured":"Townsend D, Yasuda S, Metzger J. Cardiomyopathy of Duchenne muscular dystrophy: pathogenesis and prospect of membrane sealants as a new therapeutic approach. Expert Rev Cardiovasc Ther. 2007;5(1):99\u2013109.","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"3","key":"135_CR12","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/0002-8703(94)90672-6","volume":"127","author":"J-M Kermadec de","year":"1994","unstructured":"de Kermadec J-M, et al. Prevalence of left ventricular systolic dysfunction in Duchenne muscular dystrophy An echocardiographic study. Am Heart J. 1994;127(3):618\u201323.","journal-title":"Am Heart J"},{"issue":"3","key":"135_CR13","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0960-8966(93)90060-W","volume":"3","author":"AA Ch\u00e9nard","year":"1993","unstructured":"Ch\u00e9nard AA, et al. Ventricular arrhythmia in Duchenne muscular dystrophy: prevalence, significance and prognosis. Neuromuscul Disord. 1993;3(3):201\u20136.","journal-title":"Neuromuscul Disord"},{"key":"135_CR14","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0960-8966(02)00140-2","volume":"12","author":"M Eagle","year":"2002","unstructured":"Eagle M, et al. Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscul Disord. 2002;12:926\u20139.","journal-title":"Neuromuscul Disord"},{"key":"135_CR15","doi-asserted-by":"crossref","unstructured":"Danialou, G., et al., Dystrophin-deficient cardiomyocytes are abnormally vulnerable to mechanical stress-induced contractile failure and injury. Faseb J. 2001;15(9):1655\u20137.","DOI":"10.1096\/fj.01-0030fje"},{"issue":"10","key":"135_CR16","doi-asserted-by":"crossref","first-page":"743","DOI":"10.5692\/clinicalneurol.51.743","volume":"51","author":"T Matsumura","year":"2011","unstructured":"Matsumura T, et al. A longitudinal cause-of-death analysis of patients with Duchenne muscular dystrophy. Rinsho Shinkeigaku. 2011;51(10):743\u201350.","journal-title":"Rinsho Shinkeigaku"},{"key":"135_CR17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF00687043","volume":"69","author":"Y Tanabe","year":"1986","unstructured":"Tanabe Y, Esaki K, Nomura T. Skeletal muscle pathology in X chromosome-linked muscular dystrophy (mdx) mouse. Acta Neuropathol. 1986;69:91\u20135.","journal-title":"Acta Neuropathol"},{"key":"135_CR18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2990.1988.tb00866.x","volume":"14","author":"GR Coulton","year":"1988","unstructured":"Coulton GR, et al. The mdx mouse skeletal muscle myopathy: I. A histological, morphometric and biochemical investigation. Neuropathol Appl Neurobiol. 1988;14:53\u201370.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"135_CR19","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/BF01738755","volume":"9","author":"JE Anderson","year":"1988","unstructured":"Anderson JE, Bressler BH, Ovalle WK. Functional regeneration in the hindlimb skeletal muscle of the mdx mouse. J Muscle Res Cell Motil. 1988;9:499\u2013515.","journal-title":"J Muscle Res Cell Motil"},{"key":"135_CR20","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1073\/pnas.81.4.1189","volume":"81","author":"G Bulfield","year":"1984","unstructured":"Bulfield G, et al. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci U S A. 1984;81:1189\u201392.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"135_CR21","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1365-2613.2003.00354.x","volume":"84","author":"CA Collins","year":"2003","unstructured":"Collins CA, Morgan JE. Duchenne's muscular dystrophy: animal models used to investigate pathogenesis and develop therapeutic strategies. Int J Ex Path. 2003;84:165\u201372.","journal-title":"Int J Ex Path"},{"issue":"9","key":"135_CR22","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1096\/fj.06-7353com","volume":"21","author":"JS Chamberlain","year":"2007","unstructured":"Chamberlain JS, et al. Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma. FASEB J. 2007;21(9):2195\u2013204.","journal-title":"FASEB J"},{"issue":"2","key":"135_CR23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1023\/A:1010305801236","volume":"22","author":"J Muller","year":"2001","unstructured":"Muller J, et al. Comparative evolution of muscular dystrophin in diaphragm, gastrocnemius and masseter muscles from old male mdx mice. J Muscle Res Cell Motil. 2001;22(2):133\u20139.","journal-title":"J Muscle Res Cell Motil"},{"issue":"2","key":"135_CR24","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.yjmcc.2012.05.002","volume":"53","author":"B Bostick","year":"2012","unstructured":"Bostick B, et al. AAV micro-dystrophin gene therapy alleviates stress-induced cardiac death but not myocardial fibrosis in >21-m-old mdx mice, an end-stage model of Duchenne muscular dystrophy cardiomyopathy. J Mol Cell Cardiol. 2012;53(2):217\u201322.","journal-title":"J Mol Cell Cardiol"},{"issue":"4","key":"135_CR25","doi-asserted-by":"crossref","first-page":"H303","DOI":"10.1152\/ajpheart.00485.2014","volume":"308","author":"TA Meyers","year":"2015","unstructured":"Meyers TA, Townsend D. Early right ventricular fibrosis and reduction in biventricular cardiac reserve in the dystrophin-deficient mdx heart. Am J Physiol Heart Circ Physiol. 2015;308(4):H303\u201315.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"135_CR26","doi-asserted-by":"crossref","first-page":"757","DOI":"10.7863\/ultra.32.5.757","volume":"32","author":"A Fayssoil","year":"2013","unstructured":"Fayssoil A, et al. Cardiac characterization of mdx mice using high-resolution doppler echocardiography. J Ultrasound Med. 2013;32:757\u201361.","journal-title":"J Ultrasound Med"},{"issue":"11","key":"135_CR27","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1161\/ATVBAHA.110.208108","volume":"30","author":"A Sharma","year":"2010","unstructured":"Sharma A, et al. A new role for the muscle repair protein dysferlin in endothelial cell adhesion and angiogenesis. Arterioscler Thromb Vasc Biol. 2010;30(11):2196\u2013204.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"135_CR28","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1161\/01.CIR.103.6.864","volume":"103","author":"L Loufrani","year":"2001","unstructured":"Loufrani L, et al. Flow (shear stress)-induced endothelium-dependent dilation is altered in mice lacking the gene encoding for dystrophin. Circulation. 2001;103:864\u201370.","journal-title":"Circulation"},{"key":"135_CR29","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0092-8674(92)90362-G","volume":"71","author":"AS Plump","year":"1992","unstructured":"Plump AS, et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 1992;71:343\u201353.","journal-title":"Cell"},{"key":"135_CR30","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1073\/pnas.89.10.4471","volume":"89","author":"JA Piedrahita","year":"1992","unstructured":"Piedrahita JA, et al. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc Natl Acad Sci U S A. 1992;89:4471\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"135_CR31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/nbm.1419","volume":"23","author":"NK Srivastava","year":"2010","unstructured":"Srivastava NK, et al. High resolution NMR based analysis of serum lipids in Duchenne muscular dystrophy patients and its possible diagnostic significance. NMR Biomed. 2010;23(1):13\u201322.","journal-title":"NMR Biomed"},{"key":"135_CR32","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.mri.2017.01.001","volume":"38","author":"NK Srivastava","year":"2017","unstructured":"Srivastava NK, et al. Abnormal lipid metabolism in skeletal muscle tissue of patients with muscular dystrophy: in vitro, high-resolution NMR spectroscopy based observation in early phase of the disease. Magn Reson Imaging. 2017;38:163\u201373.","journal-title":"Magn Reson Imaging"},{"issue":"1","key":"135_CR33","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2144\/00291bm09","volume":"29","author":"GE Truett","year":"2000","unstructured":"Truett GE, et al. Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and tris (HotSHOT). BioTechniques. 2000;29(1):52\u20134.","journal-title":"BioTechniques"},{"issue":"2","key":"135_CR34","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/mus.21873","volume":"43","author":"JH Shin","year":"2011","unstructured":"Shin JH, et al. Genotyping mdx, mdx3cv, and mdx4cv mice by primer competition polymerase chain reaction. Muscle Nerve. 2011;43(2):283\u20136.","journal-title":"Muscle Nerve"},{"key":"135_CR35","first-page":"e50062","volume":"73","author":"M Radu","year":"2013","unstructured":"Radu M, Chernoff J. An in vivo assay to test blood vessel permeability. J Vis Exp. 2013;73:e50062.","journal-title":"J Vis Exp"},{"issue":"6","key":"135_CR36","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/nprot.2013.055","volume":"8","author":"A Mehlem","year":"2013","unstructured":"Mehlem A, et al. Imaging of neutral lipids by oil red O for analyzing the metabolic status in health and disease. Nat Protoc. 2013;8(6):1149\u201354.","journal-title":"Nat Protoc"},{"key":"135_CR37","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1136\/jnnp.35.5.658","volume":"35","author":"BP Hughes","year":"1972","unstructured":"Hughes BP. Lipid changes in Duchenne muscular dystrophy. J Neurol Neurosurg Psychiatry. 1972;35:658\u201363.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"135_CR38","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/mus.880110809","volume":"11","author":"MJ Glesby","year":"1988","unstructured":"Glesby MJ, et al. Serum CK, calcium, magnesium, and oxidative phosphorylation in mdx mouse muscular dystrophy. Muscle Nerve. 1988;11(8):852\u20136.","journal-title":"Muscle Nerve"},{"issue":"4","key":"135_CR39","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1161\/01.ATV.0000118683.99628.42","volume":"24","author":"L Loufrani","year":"2004","unstructured":"Loufrani L, et al. Absence of dystrophin in mice reduces NO-dependent vascular function and vascular density: total recovery after a treatment with the aminoglycoside gentamicin. Arterioscler Thromb Vasc Biol. 2004;24(4):671\u20136.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"135_CR40","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1161\/01.RES.0000047505.11002.81","volume":"91","author":"L Loufrani","year":"2002","unstructured":"Loufrani L, Levy BI, Henrion D. Defect in microvascular adaptation to chronic changes in blood flow in mice lacking the gene encoding for dystrophin. Circ Res. 2002;91(12):1183\u20139.","journal-title":"Circ Res"},{"issue":"2","key":"135_CR41","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/oxfordjournals.bmb.a071625","volume":"36","author":"R Pennington","year":"1980","unstructured":"Pennington R. Clinical biochemistry of muscular dystrophy. Br Med Bull. 1980;36(2):123\u20136.","journal-title":"Br Med Bull"},{"key":"135_CR42","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0022-510X(91)90068-I","volume":"102","author":"M Zatz","year":"1991","unstructured":"Zatz M, et al. Serum creatine-kinase (CK) and pyruvate-kinase (PK) activities in Duchenne (DMD) as compared with Becker (BMD) muscular dystrophy. J Neurol Sci. 1991;102:190\u20136.","journal-title":"J Neurol Sci"},{"issue":"8\u20139","key":"135_CR43","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.nmd.2004.04.007","volume":"14","author":"JG Quinlan","year":"2004","unstructured":"Quinlan JG, et al. Evolution of the mdx mouse cardiomyopathy: physiological and morphological findings. Neuromuscul Disord. 2004;14(8\u20139):491\u20136.","journal-title":"Neuromuscul Disord"},{"key":"135_CR44","doi-asserted-by":"crossref","first-page":"13904","DOI":"10.1038\/srep13904","volume":"5","author":"A Shami","year":"2015","unstructured":"Shami A, et al. Dystrophin deficiency reduces atherosclerotic plaque development in ApoE-null mice. Sci Rep. 2015;5:13904.","journal-title":"Sci Rep"},{"key":"135_CR45","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0022-510X(68)90058-0","volume":"7","author":"CD Bell","year":"1968","unstructured":"Bell CD, Conen PE. Histopathological changes in Duchenne muscular dystrophy. J Neurol Sci. 1968;7:529\u201344.","journal-title":"J Neurol Sci"},{"issue":"4","key":"135_CR46","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00256-011-1240-1","volume":"41","author":"M Torriani","year":"2012","unstructured":"Torriani M, et al. Lower leg muscle involvement in Duchenne muscular dystrophy: an MR imaging and spectroscopy study. Skelet Radiol. 2012;41(4):437\u201345.","journal-title":"Skelet Radiol"},{"key":"135_CR47","doi-asserted-by":"crossref","unstructured":"Int J Biochem Cell Biol. 2013;45(10):2191\u20139.","DOI":"10.1016\/j.biocel.2013.05.016"},{"key":"135_CR48","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0022-510X(87)90007-4","volume":"82","author":"T Miike","year":"1987","unstructured":"Miike T, et al. Vascular endothelial cell injury and platelet embolism in Duchenne muscular dystrophy at the preclinical stage. J Neurol Sci. 1987;82:67\u201380.","journal-title":"J Neurol Sci"},{"issue":"12","key":"135_CR49","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1161\/ATVBAHA.112.301172","volume":"33","author":"M Palladino","year":"2013","unstructured":"Palladino M, et al. Angiogenic impairment of the vascular endothelium: a novel mechanism and potential therapeutic target in muscular dystrophy. Arterioscler Thromb Vasc Biol. 2013;33(12):2867\u201376.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"135_CR50","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3389\/fphys.2014.00050","volume":"5","author":"Y Shimizu-Motohashi","year":"2014","unstructured":"Shimizu-Motohashi Y, Asakura A. Angiogenesis as a novel therapeutic strategy for Duchenne muscular dystrophy through decreased ischemia and increased satellite cells. Front Physiol. 2014;5:50.","journal-title":"Front Physiol"},{"issue":"1","key":"135_CR51","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.pmr.2011.11.016","volume":"23","author":"SL Poliachik","year":"2012","unstructured":"Poliachik SL, et al. Skeletal muscle edema in muscular dystrophy: clinical and diagnostic implications. Phys Med Rehabil Clin N Am. 2012;23(1):107\u201322. xi","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"135_CR52","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0960-8966(97)00124-7","volume":"8","author":"TA Rando","year":"1988","unstructured":"Rando TA, et al. Muscle cells from mdx mice have an increased susceptibility to oxidative stress. Neuromuscul Disord. 1988;8:14\u201321.","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"135_CR53","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1152\/japplphysiol.01145.2006","volume":"102","author":"JG Tidball","year":"2007","unstructured":"Tidball JG, Wehling-Henricks M. The role of free radicals in the pathophysiology of muscular dystrophy. J Appl Physiol (1985). 2007;102(4):1677\u201386.","journal-title":"J Appl Physiol (1985)"},{"key":"135_CR54","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1440-1681.2006.04394.x","volume":"33","author":"NP Whitehead","year":"2006","unstructured":"Whitehead NP, Yeung EW, Allen DG. Muscle damage in mdx (dystrophic) mice: role of calcium and reactive oxygen species. Clin Exp Pharmacol Physiol. 2006;33:657\u201362.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"17","key":"135_CR55","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1111\/febs.12142","volume":"280","author":"JR Terrill","year":"2013","unstructured":"Terrill JR, et al. Oxidative stress and pathology in muscular dystrophies: focus on protein thiol oxidation and dysferlinopathies. FEBS J. 2013;280(17):4149\u201364.","journal-title":"FEBS J"},{"issue":"1","key":"135_CR56","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1017\/S0029665107005277","volume":"66","author":"P Schrauwen","year":"2007","unstructured":"Schrauwen P. High-fat diet, muscular lipotoxicity and insulin resistance. Proc Nutr Soc. 2007;66(1):33\u201341.","journal-title":"Proc Nutr Soc"},{"issue":"Pt 7","key":"135_CR57","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1113\/jphysiol.2008.166033","volume":"587","author":"SM Turpin","year":"2009","unstructured":"Turpin SM, et al. Examination of 'lipotoxicity' in skeletal muscle of high-fat fed and ob\/ob mice. J Physiol. 2009;587(Pt 7):1593\u2013605.","journal-title":"J Physiol"},{"issue":"1","key":"135_CR58","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.bbrc.2009.11.070","volume":"391","author":"FX Boittin","year":"2010","unstructured":"Boittin FX, et al. Phospholipase A2-derived lysophosphatidylcholine triggers Ca2+ entry in dystrophic skeletal muscle fibers. Biochem Biophys Res Commun. 2010;391(1):401\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"135_CR59","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0022-2275(20)42959-1","volume":"11","author":"K Owens","year":"1970","unstructured":"Owens K, Hughes BP. Lipids of dystrophic and normal mouse muscle: whole tissue and particulate fractions. J Lipid Res. 1970;11:486\u201395.","journal-title":"J Lipid Res"},{"issue":"3","key":"135_CR60","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cell.2011.04.005","volume":"145","author":"KJ Moore","year":"2011","unstructured":"Moore KJ, Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell. 2011;145(3):341\u201355.","journal-title":"Cell"},{"issue":"1","key":"135_CR61","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pop.2012.11.003","volume":"40","author":"RH Nelson","year":"2013","unstructured":"Nelson RH. Hyperlipidemia as a risk factor for cardiovascular disease. Prim Care. 2013;40(1):195\u2013211.","journal-title":"Prim Care"},{"key":"135_CR62","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1161\/01.ATV.14.1.133","volume":"14","author":"Y Nakashima","year":"1994","unstructured":"Nakashima Y, et al. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb Vasc Biol. 1994;14:133\u201340.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"41","key":"135_CR63","doi-asserted-by":"crossref","first-page":"12864","DOI":"10.1073\/pnas.1509536112","volume":"112","author":"NP Whitehead","year":"2015","unstructured":"Whitehead NP, et al. A new therapeutic effect of simvastatin revealed by functional improvement in muscular dystrophy. PNAS. 2015;112(41):12864\u20139.","journal-title":"PNAS"},{"issue":"9","key":"135_CR64","first-page":"1","volume":"3","author":"JP Ennen","year":"2013","unstructured":"Ennen JP, Verma M, Asakura A. Vascular-targeted therapies for Duchenne muscular dystrophy. Skelet Muscle. 2013;3(9):1\u201312.","journal-title":"Skelet Muscle"},{"issue":"1","key":"135_CR65","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/1074248410381757","volume":"16","author":"CF Spurney","year":"2011","unstructured":"Spurney CF, et al. Losartan decreases cardiac muscle fibrosis and improves cardiac function in dystrophin-deficient mdx mice. J Cardiovasc Pharmacol Ther. 2011;16(1):87\u201395.","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"8","key":"135_CR66","doi-asserted-by":"crossref","first-page":"e806","DOI":"10.1371\/journal.pone.0000806","volume":"2","author":"A Asai","year":"2007","unstructured":"Asai A, et al. Primary role of functional ischemia, quantitative evidence for the two-hit mechanism, and phosphodiesterase-5 inhibitor therapy in mouse muscular dystrophy. PLoS One. 2007;2(8):e806.","journal-title":"PLoS One"},{"issue":"4","key":"135_CR67","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/stem.1587","volume":"32","author":"N Cordani","year":"2014","unstructured":"Cordani N, et al. Nitric oxide controls fat deposition in dystrophic skeletal muscle by regulating fibro-adipogenic precursor differentiation. Stem Cells. 2014;32(4):874\u201385.","journal-title":"Stem Cells"}],"container-title":["Skeletal Muscle"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13395-017-0135-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T18:42:42Z","timestamp":1659465762000},"score":1,"resource":{"primary":{"URL":"http:\/\/skeletalmusclejournal.biomedcentral.com\/articles\/10.1186\/s13395-017-0135-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,12]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["135"],"URL":"https:\/\/doi.org\/10.1186\/s13395-017-0135-9","relation":{},"ISSN":["2044-5040"],"issn-type":[{"value":"2044-5040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,12]]},"article-number":"19"}}